Neuroinflammatory contributions to pain after SCI: Roles for central glial mechanisms and nociceptor-mediated host defense

Experimental Neurology

Volumn 258, Issue , 2014, Pages 48-61

  Walters, Edgar T ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Astrocytes; Innate immune system; Microglia; Neurogenic inflammation; Neuropathic pain; Primary afferent neurons

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIBODY; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CARBENOXOLONE; CELL CYCLE PROTEIN; CHEMOKINE RECEPTOR CCR8; CONNEXIN 43; CYCLOOXYGENASE 2 INHIBITOR; ETANERCEPT; HERPES SIMPLEX VECTOR; IBUDILAST; INTERLEUKIN 10; INTERLEUKIN 6 ANTIBODY; LICOFELONE; LIPOXYGENASE INHIBITOR; MINOCYCLINE; N (1,4 BENZODIOXAN 6 YL) 3 (4 TERT BUTYLPHENYL)ACRYLAMIDE; PROPENTOFYLLINE; PROSTAGLANDIN E2 INHIBITOR; PROSTAGLANDIN INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN INHIBITOR; RAC1 PROTEIN INHIBITOR; SECONDARY LYMPHOID TISSUE CHEMOKINE ANTIBODY; SODIUM CHANNEL NAV1.8; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; VIRUS VECTOR; AUTACOID;

CHRONIC PAIN; GENE DELETION; GLIA; HOST RESISTANCE; HUMAN; INJURY; INTRACTABLE PAIN; MACROGLIA; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PAIN RECEPTOR; PLACE PREFERENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; ANIMAL; ASTROCYTE; INNATE IMMUNITY; METABOLISM; NERVE CELL; NEUROGENIC INFLAMMATION; PAIN; PATHOLOGY; PHYSIOLOGY; PRIMARY AFFERENT NEURONS;

ASTROCYTES; INNATE IMMUNE SYSTEM; MICROGLIA; NEUROGENIC INFLAMMATION; NEUROPATHIC PAIN; PRIMARY AFFERENT NEURONS;

ANIMALS; HUMANS; INFLAMMATION MEDIATORS; NEUROGLIA; NEURONS; NOCICEPTORS; PAIN; SPINAL CORD INJURIES;

EID: 84904755354     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.02.001     Document Type: Review

References (242)

1. Abraham K.E., McMillen D., Brewer K.L. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience 2004, 124:945-952.
2. Abram S.E., Yi J., Fuchs A., Hogan Q.H. Permeability of injured and intact peripheral nerves and dorsal root ganglia. Anesthesiology 2006, 105:146-153.
3. Alano C.C., Kauppinen T.M., Valls A.V., Swanson R.A. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9685-9690.
4. Alexander J.K., Popovich P.G. Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration. Prog. Brain Res. 2009, 175:125-137.
5. Alexander J.K., DeVries A.C., Kigerl K.A., Dahlman J.M., Popovich P.G. Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav. Immun. 2009, 23:851-860.
6. Alexander J.K., Cox G.M., Tian J.B., Zha A.M., Wei P., Kigerl K.A., Reddy M.K., Dagia N.M., Sielecki T., Zhu M.X., Satoskar A.R., McTigue D.M., Whitacre C.C., Popovich P.G. Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Exp. Neurol. 2012, 236:351-362.
7. Aloisi A.M., Pari G., Ceccarelli I., Vecchi I., Ietta F., Lodi L., Paulesu L. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 2005, 115:142-151.
8. Andrews E.M., Richards R.J., Yin F.Q., Viapiano M.S., Jakeman L.B. Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury. Exp. Neurol. 2012, 235:174-187.
9. Asiedu M.N., Tillu D.V., Melemedjian O.K., Shy A., Sanoja R., Bodell B., Ghosh S., Porreca F., Price T.J. Spinal protein kinase M zeta underlies the maintenance mechanism of persistent nociceptive sensitization. J. Neurosci. 2011, 31:6646-6653.
10. Baastrup C., Maersk-Moller C.C., Nyengaard J.R., Jensen T.S., Finnerup N.B. Spinal-, brainstem- and cerebrally mediated responses at- and below-level of a spinal cord contusion in rats: evaluation of pain-like behavior. Pain 2010, 151:670-679.
11. Baldwin S.A., Broderick R., Blades D.A., ScheffS.W. Alterations in temporal/spatial distribution of GFAP- and vimentin-positive astrocytes after spinal cord contusion with the New York University spinal cord injury device. J. Neurotrauma 1998, 15:1015-1026.
12. Bareiss S.K., Gwaltney M., Hernandez K., Lee T., Brewer K.L. Excitotoxic spinal cord injury induced dysesthesias are associated with enhanced intrinsic growth of sensory neurons. Neurosci. Lett. 2013, 542:113-117.
13. Barkhof F., Hulst H.E., Drulovic J., Uitdehaag B.M., Matsuda K., Landin R. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?. Neurology 2010, 74:1033-1040.
14. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
15. Beck K.D., Nguyen H.X., Galvan M.D., Salazar D.L., WoodruffT.M., Anderson A.J. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447.
16. Bedi S.S., Yang Q., Crook R.J., Du J., Wu Z., Fishman H.M., Grill R.J., Carlton S.M., Walters E.T. Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury. J. Neurosci. 2010, 30:14870-14882.
17. Bedi S.S., Lago M.T., Masha L.I., Crook R.J., Grill R.J., Walters E.T. Spinal cord injury triggers an intrinsic growth-promoting state in nociceptors. J. Neurotrauma 2012, 29:925-935.
18. Beggs S., Liu X.J., Kwan C., Salter M.W. Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Mol. Pain 2010, 6:74.
19. Benowitz L.I., Popovich P.G. Inflammation and axon regeneration. Curr. Opin. Neurol. 2011, 24:577-583.
20. Bijjiga E., Martino A.T. Interleukin 10 (IL-10) regulatory cytokine and its clinical consequences. J. Clin. Cell Immunol. 2013, S1:007.
21. Boroujerdi A., Zeng J., Sharp K., Kim D., Steward O., Luo Z.D. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain 2011, 152:649-655.
22. Brooks T.A., Hawkins B.T., Huber J.D., Egleton R.D., Davis T.P. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H738-H743.
23. Bruce J.C., Oatway M.A., Weaver L.C. Chronic pain after clip-compression injury of the rat spinal cord. Exp. Neurol. 2002, 178:33-48.
24. Bryce T.N., Biering-Sorensen F., Finnerup N.B., Cardenas D.D., Defrin R., Lundeberg T., Norrbrink C., Richards J.S., Siddall P., Stripling T., Treede R.D., Waxman S.G., Widerstrom-Noga E., Yezierski R.P., Dijkers M. International spinal cord injury pain classification: part I. Background and description. Spinal Cord 2012, 50:413-417.
25. Bucala R. MIF re-discovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. Cytokine Growth Factor Rev. 1996, 7:19-24.
26. Byrnes K.R., Faden A.I. Role of cell cycle proteins in CNS injury. Neurochem. Res. 2007, 32:1799-1807.
27. Byrnes K.R., Washington P.M., Knoblach S.M., Hoffman E., Faden A.I. Delayed inflammatory mRNA and protein expression after spinal cord injury. J. Neuroinflammation 2011, 8:130.
28. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
29. Calvo M., Bennett D.L. The mechanisms of microgliosis and pain following peripheral nerve injury. Exp. Neurol. 2012, 234:271-282.
30. Cardenas D.D., Jensen M.P. Treatments for chronic pain in persons with spinal cord injury: a survey study. J. Spinal Cord Med. 2006, 29:109-117.
31. Cardenas D.D., NieshoffE.C., Suda K., Goto S., Sanin L., Kaneko T., Sporn J., Parsons B., Soulsby M., Yang R., Whalen E., Scavone J.M., Suzuki M.M., Knapp L.E. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology 2013, 80:533-539.
32. Carlton S.M., Du J., Tan H.Y., Nesic O., Hargett G.L., Bopp A.C., Yamani A., Lin Q., Willis W.D., Hulsebosch C.E. Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain 2009, 147:265-276.
33. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313.
34. Chen Y., Willcockson H.H., ValtschanoffJ.G. Influence of the vanilloid receptor TRPV1 on the activation of spinal cord glia in mouse models of pain. Exp. Neurol. 2009, 220:383-390.
35. Chen M.J., Kress B., Han X., Moll K., Peng W., Ji R.R., Nedergaard M. Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury. Glia 2012, 60:1660-1670.
36. Chiu I.M., von Hehn C.A., Woolf C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci. 2012, 15:1063-1067.
37. Chiu I.M., Heesters B.A., Ghasemlou N., Von Hehn C.A., Zhao F., Tran J., Wainger B., Strominger A., Muralidharan S., Horswill A.R., Bubeck Wardenburg J., Hwang S.W., Carroll M.C., Woolf C.J. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 2013, 501:52-57.
38. Chizh B.A., O'Donnell M.B., Napolitano A., Wang J., Brooke A.C., Aylott M.C., Bullman J.N., Gray E.J., Lai R.Y., Williams P.M., Appleby J.M. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 2007, 132:132-141.
39. Choi D.C., Lee J.Y., Lim E.J., Baik H.H., Oh T.H., Yune T.Y. Inhibition of ROS-induced p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after spinal cord injury in rats. Exp. Neurol. 2012, 236:268-282.
40. Christensen M.D., Everhart A.W., Pickelman J.T., Hulsebosch C.E. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain 1996, 68:97-107.
41. Chu Y.X., Zhang Y.Q., Zhao Z.Q. Involvement of microglia and interleukin-18 in the induction of long-term potentiation of spinal nociceptive responses induced by tetanic sciatic stimulation. Neurosci. Bull. 2012, 28:49-60.
42. Colburn R.W., Rickman A.J., DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol. 1999, 157:289-304.
43. Costigan M., Scholz J., Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 2009, 32:1-32.
44. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
45. Crown E.D., Ye Z., Johnson K.M., Xu G.Y., McAdoo D.J., Hulsebosch C.E. Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp. Neurol. 2006, 199:397-407.
46. Crown E.D., Gwak Y.S., Ye Z., Johnson K.M., Hulsebosch C.E. Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury. Exp. Neurol. 2008, 213:257-267.
47. Davies A.L., Hayes K.C., Dekaban G.A. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch. Phys. Med. Rehabil. 2007, 88:1384-1393.
48. Davoody L., Quiton R.L., Lucas J.M., Ji Y., Keller A., Masri R. Conditioned place preference reveals tonic pain in an animal model of central pain. J. Pain 2011, 12:868-874.
49. del Rey A., Balschun D., Wetzel W., Randolf A., Besedovsky H.O. A cytokine network involving brain-borne IL-1beta, IL-1ra, IL-18, IL-6, and TNFalpha operates during long-term potentiation and learning. Brain Behav. Immun. 2013, 33:15-23.
50. DeLeo J.A., Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001, 90:1-6.
51. DeLeo J.A., Colburn R.W., Nichols M., Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 1996, 16:695-700.
52. DetloffM.R., Fisher L.C., McGaughy V., Longbrake E.E., Popovich P.G., Basso D.M. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp. Neurol. 2008, 212:337-347.
53. DetloffM.R., Wade R.E.J., Houle J.D. Chronic at- and below-level pain after moderate unilateral cervical spinal cord contusion in rats. J. Neurotrauma 2013, 30:884-890.
54. Dijkers M., Bryce T., Zanca J. Prevalence of chronic pain after traumatic spinal cord injury: a systematic review. J. Rehabil. Res. Dev. 2009, 46:13-29.
55. Dijkstra S., Geisert E.E.J.R., Gispen W.H., Bar P.R., Joosten E.A. Up-regulation of CD81 (target of the antiproliferative antibody; TAPA) by reactive microglia and astrocytes after spinal cord injury in the rat. J. Comp. Neurol. 2000, 428:266-277.
56. DomBourian M.G., Turner N.A., Gerovac T.A., Vemuganti R., Miranpuri G.S., Tureyen K., Satriotomo I., Miletic V., Resnick D.K. B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine (Phila Pa 1976) 2006, 31:2778-2782.
57. Dong F., Du Y.R., Xie W., Strong J.A., He X.J., Zhang J.M. Increased function of the TRPV1 channel in small sensory neurons after local inflammation or in vitro exposure to the pro-inflammatory cytokine GRO/KC. Neurosci. Bull. 2012, 28:155-164.
58. Drew G.M., Siddall P.J., Duggan A.W. Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn. Pain 2004, 109:379-388.
59. Dulin J.N., Karoly E.D., Wang Y., Strobel H.W., Grill R.J. Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury. J. Neurosci. 2013, 33:652-664.
60. Dulin J.N., Moore M.L., Grill R.J. The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord. J. Neurotrauma 2013, 30:211-226.
61. Ellis A., Bennett D.L. Neuroinflammation and the generation of neuropathic pain. Br. J. Anaesth. 2013, 111:26-37.
62. Ewan E.E., Martin T.J. Analgesics as reinforcers with chronic pain: evidence from operant studies. Neurosci. Lett. 2013, 557 Pt A:60-64.
63. Fenner B.M. Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev. 2012, 23:15-24.
64. Finnerup N.B., Baastrup C. Spinal cord injury pain: mechanisms and management. Curr. Pain Headache Rep. 2012, 16:207-216.
65. Finnerup N.B., Jensen T.S. Spinal cord injury pain-mechanisms and treatment. Eur. J. Neurol. 2004, 11:73-82.
66. Finnerup N.B., Gyldensted C., Fuglsang-Frederiksen A., Bach F.W., Jensen T.S. Sensory perception in complete spinal cord injury. Acta Neurol. Scand. 2004, 109:194-199.
67. Finnerup N.B., Norrbrink C., Trok K., Piehl F., Johannesen I.L., Sorensen J.C., Jensen T.S., Werhagen L. Phenotypes and predictors of pain following traumatic spinal cord injury: a prospective study. J. Pain 2014, 15:40-48.
68. Flaster H., Bernhagen J., Calandra T., Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol. Endocrinol. 2007, 21:1267-1280.
69. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquale-Styles M., Dietrich W.D., Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129:3249-3269.
70. Fukuda A.M., Badaut J. Aquaporin 4: a player in cerebral edema and neuroinflammation. J. Neuroinflammation 2012, 9:279.
71. Gao Y.J., Zhang L., Ji R.R. Spinal injection of TNF-alpha-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1. Glia 2010, 58:1871-1880.
72. Garrido-Mesa N., Zarzuelo A., Galvez J. Minocycline: far beyond an antibiotic. Br. J. Pharmacol. 2013, 169:337-352.
73. Gavva N.R., Treanor J.J., Garami A., Fang L., Surapaneni S., Akrami A., Alvarez F., Bak A., Darling M., Gore A., Jang G.R., Kesslak J.P., Ni L., Norman M.H., Palluconi G., Rose M.J., SalfiM., Tan E., Romanovsky A.A., Banfield C., Davar G. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 2008, 136:202-210.
74. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
75. Giulian D., Li J., Leara B., Keenen C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 1994, 25:227-233.
76. Gordh T., Chu H., Sharma H.S. Spinal nerve lesion alters blood-spinal cord barrier function and activates astrocytes in the rat. Pain 2006, 124:211-221.
77. Graeber M.B., Christie M.J. Multiple mechanisms of microglia: a gatekeeper's contribution to pain states. Exp. Neurol. 2012, 234:255-261.
78. Gruber-Schoffnegger D., Drdla-Schutting R., Honigsperger C., Wunderbaldinger G., Gassner M., Sandkuhler J. Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-alpha and IL-1beta is mediated by glial cells. J. Neurosci. 2013, 33:6540-6551.
79. Guptarak J., Wanchoo S., Durham-Lee J., Wu Y., Zivadinovic D., Paulucci-Holthauzen A., Nesic O. Inhibition of IL-6 signaling: A novel therapeutic approach to treating spinal cord injury pain. Pain 2013, 154:1115-1128.
80. Gwak Y.S., Hulsebosch C.E. Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat. Neuroscience 2009, 161:895-903.
81. Gwak Y.S., Hulsebosch C.E. Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury. Curr. Pain Headache Rep. 2011, 15:215-222.
82. Gwak Y.S., Tan H.Y., Nam T.S., Paik K.S., Hulsebosch C.E., Leem J.W. Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. J. Neurotrauma 2006, 23:1111-1124.
83. Gwak Y.S., Crown E.D., Unabia G.C., Hulsebosch C.E. Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat. Pain 2008, 138:410-422.
84. Gwak Y.S., Unabia G.C., Hulsebosch C.E. Activation of p-38alpha MAPK contributes to neuronal hyperexcitability in caudal regions remote from spinal cord injury. Exp. Neurol. 2009, 220:154-161.
85. Gwak Y.S., Kang J., Unabia G.C., Hulsebosch C.E. Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp. Neurol. 2012, 234:362-372.
86. Hains B.C., Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 2006, 26:4308-4317.
87. Hains B.C., Yucra J.A., Hulsebosch C.E. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J. Neurotrauma 2001, 18:409-423.
88. Hains B.C., Everhart A.W., Fullwood S.D., Hulsebosch C.E. Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp. Neurol. 2002, 175:347-362.
89. Hains B.C., Klein J.P., Saab C.Y., Craner M.J., Black J.A., Waxman S.G. Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci. 2003, 23:8881-8892.
90. Hains B.C., Saab C.Y., Waxman S.G. Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury. Brain 2005, 128:2359-2371.
91. Hama A.T., Broadhead A., Lorrain D.S., Sagen J. The antinociceptive effect of the asthma drug ibudilast in rat models of peripheral and central neuropathic pain. J. Neurotrauma 2012, 29:600-610.
92. Hathway G.J., Vega-Avelaira D., Moss A., Ingram R., Fitzgerald M. Brief, low frequency stimulation of rat peripheral C-fibres evokes prolonged microglial-induced central sensitization in adults but not in neonates. Pain 2009, 144:110-118.
93. Hawthorne A.L., Popovich P.G. Emerging concepts in myeloid cell biology after spinal cord injury. Neurotherapeutics 2011, 8:252-261.
94. Hayes K.C., Hull T.C., Delaney G.A., Potter P.J., Sequeira K.A., Campbell K., Popovich P.G. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J. Neurotrauma 2002, 19:753-761.
95. Hou S., Duale H., Rabchevsky A.G. Intraspinal sprouting of unmyelinated pelvic afferents after complete spinal cord injury is correlated with autonomic dysreflexia induced by visceral pain. Neuroscience 2009, 159:369-379.
96. Huang L.Y., Gu Y., Chen Y. Communication between neuronal somata and satellite glial cells in sensory ganglia. Glia 2013, 61:1571-1581.
97. Huber J.D., Witt K.A., Hom S., Egleton R.D., Mark K.S., Davis T.P. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H1241-H1248.
98. Hulsebosch C.E. Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp. Neurol. 2008, 214:6-9.
99. Hulsebosch C.E., Hains B.C., Crown E.D., Carlton S.M. Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res. Rev. 2009, 60:202-213.
100. Jang J.H., Clark J.D., Li X., Yorek M.S., Usachev Y.M., Brennan T.J. Nociceptive sensitization by complement C5a and C3a in mouse. Pain 2010, 148:343-352.
101. Jensen T.S., Baron R., Haanpaa M., Kalso E., Loeser J.D., Rice A.S., Treede R.D. A new definition of neuropathic pain. Pain 2011, 152:2204-2205.
102. Ji R.R., Xu Z.Z., Strichartz G., Serhan C.N. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 2011, 34:599-609.
103. Ji R.R., Berta T., Nedergaard M. Glia and pain: is chronic pain a gliopathy?. Pain 2013, 154 Suppl 1:S10-28.
104. Jimenez-Andrade J.M., Herrera M.B., Ghilardi J.R., Vardanyan M., Melemedjian O.K., Mantyh P.W. Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies. Mol. Pain 2008, 4:10.
105. Jung H., Toth P.T., White F.A., Miller R.J. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J. Neurochem. 2008, 104:254-263.
106. Kalliomaki J., Attal N., Jonzon B., Bach F.W., Huizar K., Ratcliffe S., Eriksson B., Janecki M., Danilov A., Bouhassira D. A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia. Pain 2013, 154:761-767.
107. Karimi-Abdolrezaee S., Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol. Neurobiol. 2012, 46:251-264.
108. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 2008, 28:5189-5194.
109. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
110. Kim T.H., Kim H.I., Kim J., Park M., Song J.H. Effects of minocycline on Na+ currents in rat dorsal root ganglion neurons. Brain Res. 2011, 1370:34-42.
111. Kim Y.H., Back S.K., Davies A.J., Jeong H., Jo H.J., Chung G., Na H.S., Bae Y.C., Kim S.J., Kim J.S., Jung S.J., Oh S.B. TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron 2012, 74:640-647.
112. King T., Vera-Portocarrero L., Gutierrez T., Vanderah T.W., Dussor G., Lai J., Fields H.L., Porreca F. Unmasking the tonic-aversive state in neuropathic pain. Nat. Neurosci. 2009, 12:1364-1366.
113. Koshinaga M., Whittemore S.R. The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J. Neurotrauma 1995, 12:209-222.
114. Kraft A.D., McPherson C.A., Harry G.J. Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. Neurotoxicology 2009, 30:785-793.
115. Krarup A.L., Ny L., Astrand M., Bajor A., Hvid-Jensen F., Hansen M.B., Simren M., Funch-Jensen P., Drewes A.M. Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment. Pharmacol. Ther. 2011, 33:1113-1122.
116. Krarup A.L., Ny L., Gunnarsson J., Hvid-Jensen F., Zetterstrand S., Simren M., Funch-Jensen P., Hansen M.B., Drewes A.M. Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain. Scand. J. Gastroenterol. 2013, 48:274-284.
117. Krenz N.R., Weaver L.C. Sprouting of primary afferent fibers after spinal cord transection in the rat. Neuroscience 1998, 85:443-458.
118. Kwon B.K., Stammers A.M., Belanger L.M., Bernardo A., Chan D., Bishop C.M., Slobogean G.P., Zhang H., Umedaly H., Giffin M., Street J., Boyd M.C., Paquette S.J., Fisher C.G., Dvorak M.F. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma 2010, 27:669-682.
119. Laferriere A., Pitcher M.H., Haldane A., Huang Y., Cornea V., Kumar N., Sacktor T.C., Cervero F., Coderre T.J. PKMzeta is essential for spinal plasticity underlying the maintenance of persistent pain. Mol. Pain 2011, 7:99.
120. Landry R.P., Jacobs V.L., Romero-Sandoval E.A., DeLeo J.A. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp. Neurol 2012, 234:340-350.
121. Lau D., Harte S.E., Morrow T.J., Wang S., Mata M., Fink D.J. Herpes simplex virus vector-mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury. Neurorehabil. Neural Repair 2012, 26:889-897.
122. Lauria G., Morbin M., Lombardi R., Capobianco R., Camozzi F., Pareyson D., Manconi M., Geppetti P. Expression of capsaicin receptor immunoreactivity in human peripheral nervous system and in painful neuropathies. J. Peripher. Nerv. Syst. 2006, 11:262-271.
123. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115:71-83.
124. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., Berman J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 1993, 150:2659-2667.
125. Lee J.Y., Choi D.C., Oh T.H., Yune T.Y. Analgesic effect of acupuncture is mediated via inhibition of JNK activation in astrocytes after spinal cord injury. PLoS One 2013, 8:e73948.
126. Liebl D.J., Huang W., Young W., Parada L.F. Regulation of Trk receptors following contusion of the rat spinal cord. Exp. Neurol. 2001, 167:15-26.
127. Lin C.Y., Lee Y.S., Lin V.W., Silver J. Fibronectin inhibits chronic pain development after spinal cord injury. J. Neurotrauma 2012, 29:589-599.
128. Liu M., Wood J.N. The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain. Pain Med. 2011, 12(Suppl. 3):S93-S99.
129. Lucin K.M., Sanders V.M., Popovich P.G. Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J. Neurochem. 2009, 110:1409-1421.
130. Marchand F., Tsantoulas C., Singh D., Grist J., Clark A.K., Bradbury E.J., McMahon S.B. Effects of etanercept and minocycline in a rat model of spinal cord injury. Eur. J. Pain 2009, 13:673-681.
131. Marchand F., D'Mello R., Yip P.K., Calvo M., Muller E., Pezet S., Dickenson A.H., McMahon S.B. Specific involvement of atypical PKCzeta/PKMzeta in spinal persistent nociceptive processing following peripheral inflammation in rat. Mol. Pain 2011, 7:86.
132. Matsumoto Y., Park I.K., Kohyama K. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy. J. Immunol. 2009, 183:4773-4781.
133. McKay S.M., McLachlan E.M. Inflammation of rat dorsal root ganglia below a mid-thoracic spinal transection. Neuroreport 2004, 15:1783-1786.
134. McMahon S.B., Malcangio M. Current challenges in glia-pain biology. Neuron 2009, 64:46-54.
135. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
136. Meisner J.G., Marsh A.D., Marsh D.R. Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. J. Neurotrauma 2010, 27:729-737.
137. Mendell L.M. Computational functions of neurons and circuits signaling injury: relationship to pain behavior. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(Suppl. 3):15596-15601.
138. Merighi A., Salio C., Ghirri A., Lossi L., Ferrini F., Betelli C., Bardoni R. BDNF as a pain modulator. Prog. Neurobiol. 2008, 85:297-317.
139. Mika J., Zychowska M., Popiolek-Barczyk K., Rojewska E., Przewlocka B. Importance of glial activation in neuropathic pain. Eur. J. Pharmacol. 2013, 716:109-119.
140. Miller R.J., Jung H., Bhangoo S.K., White F.A. Cytokine and chemokine regulation of sensory neuron function. Handb. Exp. Pharmacol. 2009, 417-449.
141. Milligan E.D., Penzkover K.R., Soderquist R.G., Mahoney M.J. Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation 2012, 15:520-526. (discussion 526).
142. Miyamoto T., Dubin A.E., Petrus M.J., Patapoutian A. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One 2009, 4:e7596.
143. Montgomery S.L., Bowers W.J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol. 2012, 7:42-59.
144. Morales-Lazaro S.L., Simon S.A., Rosenbaum T. The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1). J. Physiol. 2013, 591:3109-3121.
145. Murphy K., 2012. Janeyway's Immunobiology, 8th ed. Garland Science, pp. 37, 75.
146. Nardone R., Holler Y., Brigo F., Seidl M., Christova M., Bergmann J., Golaszewski S., Trinka E. Functional brain reorganization after spinal cord injury: systematic review of animal and human studies. Brain Res. 2013, 1504:58-73.
147. Naseri K., Saghaei E., Abbaszadeh F., Afhami M., Haeri A., Rahimi F., Jorjani M. Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats. J. Mol. Neurosci. 2013, 49:470-479.
148. Navratilova E., Xie J.Y., King T., Porreca F. Evaluation of reward from pain relief. Ann. N. Y. Acad. Sci. 2013, 1282:1-11.
149. Nesic O., Lee J., Johnson K.M., Ye Z., Xu G.Y., Unabia G.C., Wood T.G., McAdoo D.J., Westlund K.N., Hulsebosch C.E., Regino Perez-Polo J. Transcriptional profiling of spinal cord injury-induced central neuropathic pain. J. Neurochem. 2005, 95:998-1014.
150. Nishio N., Taniguchi W., Sugimura Y.K., Takiguchi N., Yamanaka M., Kiyoyuki Y., Yamada H., Miyazaki N., Yoshida M., Nakatsuka T. Reactive oxygen species enhance excitatory synaptic transmission in rat spinal dorsal horn neurons by activating TRPA1 and TRPV1 channels. Neuroscience 2013, 247:201-212.
151. Noble L.J., Wrathall J.R. The blood-spinal cord barrier after injury: pattern of vascular events proximal and distal to a transection in the rat. Brain Res. 1987, 424:177-188.
152. Noguchi K., Okubo M. Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain. Biol. Pharm. Bull. 2011, 34:1163-1169.
153. O'Brien M.F., Lenke L.G., Lou J., Bridwell K.H., Joyce M.E. Astrocyte response and transforming growth factor-beta localization in acute spinal cord injury. Spine (Phila Pa 1976) 1994, 19:2321-2329. (discussion 2330).
154. Ohara P.T., Vit J.P., Bhargava A., Romero M., Sundberg C., Charles A.C., Jasmin L. Gliopathic pain: when satellite glial cells go bad. Neuroscientist 2009, 15:450-463.
155. Okun A., DeFelice M., Eyde N., Ren J., Mercado R., King T., Porreca F. Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents. Mol. Pain 2011, 7:4.
156. Ondarza A.B., Ye Z., Hulsebosch C.E. Direct evidence of primary afferent sprouting in distant segments following spinal cord injury in the rat: colocalization of GAP-43 and CGRP. Exp. Neurol. 2003, 184:373-380.
157. Onifer S.M., Rabchevsky A.G., ScheffS.W. Rat models of traumatic spinal cord injury to assess motor recovery. ILAR J. 2007, 48:385-395.
158. Owolabi S.A., Saab C.Y. Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn. FEBS Lett. 2006, 580:4306-4310.
159. Perea G., Araque A. Astrocytes potentiate transmitter release at single hippocampal synapses. Science 2007, 317:1083-1086.
160. Pezet S., McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. 2006, 29:507-538.
161. Plunkett J.A., Yu C.G., Easton J.M., Bethea J.R., Yezierski R.P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 2001, 168:144-154.
162. Popovich P.G., Horner P.J., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 1996, 142:258-275.
163. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 1997, 377:443-464.
164. Raghavendra V., Tanga F., DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 2003, 306:624-630.
165. Rahn E.J., Guzman-Karlsson M.C., David Sweatt J. Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memory. Neurobiol. Learn. Mem. 2013, 105:133-150.
166. Rajpal S., Gerovac T.A., Turner N.A., Tilghman J.I., Allcock B.K., McChesney S.L., Miranpuri G.S., Park S.W., Resnick D.K. Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats. J. Neurosurg. Spine 2007, 6:420-424.
167. Ramer L.M., van Stolk A.P., Inskip J.A., Ramer M.S., Krassioukov A.V. Plasticity of TRPV1-expressing sensory neurons mediating autonomic dysreflexia following spinal cord injury. Front. Physiol. 2012, 3:257.
168. Ramesh G., Maclean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediat. Inflamm. 2013, 2013:480739.
169. RansohoffR.M., Brown M.A. Innate immunity in the central nervous system. J. Clin. Invest. 2012, 122:1164-1171.
170. Raynauld J.P., Martel-Pelletier J., Bias P., Laufer S., Haraoui B., Choquette D., Beaulieu A.D., Abram F., Dorais M., Vignon E., Pelletier J.P. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann. Rheum. Dis. 2009, 68:938-947.
171. Reeve A.J., Patel S., Fox A., Walker K., Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur. J. Pain 2000, 4:247-257.
172. Reilly R.M., McDonald H.A., Puttfarcken P.S., Joshi S.K., Lewis L., Pai M., Franklin P.H., Segreti J.A., Neelands T.R., Han P., Chen J., Mantyh P.W., Ghilardi J.R., Turner T.M., Voight E.A., Daanen J.F., Schmidt R.G., Gomtsyan A., Kort M.E., Faltynek C.R., Kym P.R. Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature. J. Pharmacol. Exp. Ther. 2012, 342:416-428.
173. Richardson J.D., Vasko M.R. Cellular mechanisms of neurogenic inflammation. J. Pharmacol. Exp. Ther. 2002, 302:839-845.
174. Rintala D.H., Holmes S.A., Courtade D., Fiess R.N., Tastard L.V., Loubser P.G. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch. Phys. Med. Rehabil. 2007, 88:1547-1560.
175. Roh D.H., Yoon S.Y., Seo H.S., Kang S.Y., Han H.J., Beitz A.J., Lee J.H. Intrathecal injection of carbenoxolone, a gap junction decoupler, attenuates the induction of below-level neuropathic pain after spinal cord injury in rats. Exp. Neurol. 2010, 224:123-132.
176. Rowbotham M.C., Nothaft W., Duan W.R., Wang Y., Faltynek C., McGaraughty S., Chu K.L., Svensson P. Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial. Pain 2011, 152:1192-1200.
177. Schaffler K., Reeh P., Duan W.R., Best A.E., Othman A.A., Faltynek C.R., Locke C., Nothaft W. An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin. Br. J. Clin. Pharmacol. 2013, 75:404-414.
178. Schomberg D., Olson J.K. Immune responses of microglia in the spinal cord: contribution to pain states. Exp. Neurol. 2012, 234:262-270.
179. Schwab J.M., Guo L., Schluesener H.J. Spinal cord injury induces early and persistent lesional P2X4 receptor expression. J. Neuroimmunol. 2005, 163:185-189.
180. Segal J.L., Gonzales E., YousefiS., Jamshidipour L., Brunnemann S.R. Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. Arch. Phys. Med. Rehabil. 1997, 78:44-47.
181. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
182. Shibasaki M., Sasaki M., Miura M., Mizukoshi K., Ueno H., Hashimoto S., Tanaka Y., Amaya F. Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 2010, 149:514-521.
183. Shields S.D., Ahn H.S., Yang Y., Han C., Seal R.P., Wood J.N., Waxman S.G., Dib-Hajj S.D. Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system. Pain 2012, 153:2017-2030.
184. Siddall P., Xu C.L., Cousins M. Allodynia following traumatic spinal cord injury in the rat. Neuroreport 1995, 6:1241-1244.
185. Siddall P.J., Cousins M.J., Otte A., Griesing T., Chambers R., Murphy T.K. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006, 67:1792-1800.
186. Skaper S.D., Giusti P., Facci L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. 2012, 26:3103-3117.
187. Sotocinal S.G., Sorge R.E., Zaloum A., Tuttle A.H., Martin L.J., Wieskopf J.S., Mapplebeck J.C., Wei P., Zhan S., Zhang S., McDougall J.J., King O.D., Mogil J.S. The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol. Pain 2011, 7:55.
188. Stein A., Panjwani A., Sison C., Rosen L., Chugh R., Metz C., Bank M., Bloom O. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury. Arch. Phys. Med. Rehabil. 2013, 94:1498-1507.
189. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
190. Strong J.A., Xie W., Coyle D.E., Zhang J.M. Microarray analysis of rat sensory ganglia after local inflammation implicates novel cytokines in pain. PLoS One 2012, 7:e40779.
191. Sufka K.J. Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 1994, 58:355-366.
192. Sumracki N.M., Hutchinson M.R., Gentgall M., Briggs N., Williams D.B., Rolan P. The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica. PLoS One 2012, 7:e38525.
193. Suter M.R., Berta T., Gao Y.J., Decosterd I., Ji R.R. Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury. Mol. Pain 2009, 5:53.
194. Sweitzer S.M., Colburn R.W., Rutkowski M., DeLeo J.A. Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res. 1999, 829:209-221.
195. Sweitzer S.M., Hickey W.F., Rutkowski M.D., Pahl J.L., DeLeo J.A. Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain 2002, 100:163-170.
196. Tan A.M., Waxman S.G. Spinal cord injury, dendritic spine remodeling, and spinal memory mechanisms. Exp. Neurol. 2012, 235:142-151.
197. Tan A.M., Stamboulian S., Chang Y.W., Zhao P., Hains A.B., Waxman S.G., Hains B.C. Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. J. Neurosci. 2008, 28:13173-13183.
198. Tan A.M., Zhao P., Waxman S.G., Hains B.C. Early microglial inhibition preemptively mitigates chronic pain development after experimental spinal cord injury. J. Rehabil. Res. Dev. 2009, 46:123-133.
199. Taves S., Berta T., Chen G., Ji R.R. Microglia and spinal cord synaptic plasticity in persistent pain. Neural Plast. 2013, 2013:753656.
200. Teasell R.W., Mehta S., Aubut J.A., Foulon B., Wolfe D.L., Hsieh J.T., Townson A.F., Short C. A systematic review of pharmacologic treatments of pain after spinal cord injury. Arch. Phys. Med. Rehabil. 2010, 91:816-831.
201. Tenorio G., Kulkarni A., Kerr B.J. Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain. Pain 2013, 154:71-81.
202. Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D., Thompson S.W., Marchand F., McMahon S.B. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur. J. Pain 2009, 13:263-272.
203. Thompson C.D., Zurko J.C., Hanna B.F., Hellenbrand D.J., Hanna A. The therapeutic role of interleukin-10 after spinal cord injury. J. Neurotrauma 2013, 30:1311-1324.
204. Trang T., Beggs S., Salter M.W. Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol. 2011, 7:99-108.
205. Ulgen B.O., Field M.G., Qureshi W., Knight R.A., Stephanou A., Latchman D.S., Vasquez D., Barry S.P., Saravolatz L.N., Scarabelli G.M., Faggian G., Mazzucco A., Saravolatz L., Chen-Scarabelli C., Scarabelli T.M. The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications. Recent Pat. Cardiovasc. Drug Discov. 2011, 6:123-132.
206. Van Steenwinckel J., Reaux-Le Goazigo A., Pommier B., Mauborgne A., Dansereau M.A., Kitabgi P., Sarret P., Pohl M., Melik Parsadaniantz S. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J. Neurosci. 2011, 31:5865-5875.
207. Vierck C.J.J., Siddall P., Yezierski R.P. Pain following spinal cord injury: animal models and mechanistic studies. Pain 2000, 89:1-5.
208. Vierck C.J., Cannon R.L., Acosta-Rua A.J. Evaluation of lateral spinal hemisection as a preclinical model of spinal cord injury pain. Exp. Brain Res. 2013, 228:305-312.
209. Walters E.T. Nociceptors as chronic drivers of pain and hyperreflexia after spinal cord injury: an adaptive-maladaptive hyperfunctional state hypothesis. Front. Physiol. 2012, 3:309.
210. Wang G., Thompson S.M. Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyperexcitability after spinothalamic tract lesions. J. Neurosci. 2008, 28:11959-11969.
211. Wang J.G., Strong J.A., Xie W., Zhang J.M. Local inflammation in rat dorsal root ganglion alters excitability and ion currents in small-diameter sensory neurons. Anesthesiology 2007, 107:322-332.
212. Wang F., Shen X., Guo X., Peng Y., Liu Y., Xu S., Yang J. Spinal macrophage migration inhibitory factor contributes to the pathogenesis of inflammatory hyperalgesia in rats. Pain 2010, 148:275-283.
213. Wang F., Xu S., Shen X., Guo X., Peng Y., Yang J. Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity. Anesthesiology 2011, 114:643-659.
214. Wasner G., Lee B.B., Engel S., McLachlan E. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain 2008, 131:2387-2400.
215. Watanabe T., Yamamoto T., Abe Y., Saito N., Kumagai T., Kayama H. Differential activation of microglia after experimental spinal cord injury. J. Neurotrauma 1999, 16:255-265.
216. Watkins L.R., Milligan E.D., Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001, 24:450-455.
217. Wen Y.R., Suter M.R., Kawasaki Y., Huang J., Pertin M., Kohno T., Berde C.B., Decosterd I., Ji R.R. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 2007, 107:312-321.
218. Whitt J.L., Masri R., Pulimood N.S., Keller A. Pathological activity in mediodorsal thalamus of rats with spinal cord injury pain. J. Neurosci. 2013, 33:3915-3926.
219. Wiech K., Ploner M., Tracey I. Neurocognitive aspects of pain perception. Trends Cogn. Sci. 2008, 12:306-313.
220. Wieseler J., Ellis A.L., McFadden A., Brown K., Starnes C., Maier S.F., Watkins L.R., Falci S. Below level central pain induced by discrete dorsal spinal cord injury. J. Neurotrauma 2010, 27:1697-1707.
221. Wildi L.M., Raynauld J.P., Martel-Pelletier J., Abram F., Dorais M., Pelletier J.P. Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI. Ann. Rheum. Dis. 2010, 69:2118-2124.
222. Wu J., Pajoohesh-Ganji A., Stoica B.A., Dinizo M., Guanciale K., Faden A.I. Delayed expression of cell cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusion. J. Neuroinflammation 2012, 9:169.
223. Wu J., Raver C., Piao C., Keller A., Faden A.I. Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperesthesia after rat spinal cord contusion. Neurotherapeutics 2013, 10:520-538.
224. Wu J., Renn C.L., Faden A.I., Dorsey S.G. TrkB.T1 contributes to neuropathic pain after spinal cord injury through regulation of cell cycle pathways. J. Neurosci. 2013, 33:12447-12463.
225. Wu Z., Yang Q., Crook R.J., O'Neil R.G., Walters E.T. TRPV1 channels make major contributions to behavioral hypersensitivity and spontaneous activity in nociceptors after spinal cord injury. Pain 2013, 154:2130-2141.
226. Xanthos D.N., Sandkuhler J. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat. Rev. Neurosci. 2014, 15:43-53.
227. Xie W.R., Deng H., Li H., Bowen T.L., Strong J.A., Zhang J.M. Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience 2006, 142:809-822.
228. Xie W., Strong J.A., Zhang J.M. Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models. Neuroscience 2009, 160:847-857.
229. Yang Q., Wu Z.Z., Crook R.J., Walters E.T. Knockdown of Nav1.8 blocks both spontaneous activity in small DRG neurons and reflex hypersensitivity after spinal cord injury. Soc. Neurosci. Abstr. 2012, 67.05.
230. Yezierski R.P. Spinal cord injury pain: spinal and supraspinal mechanisms. J. Rehabil. Res. Dev. 2009, 46:95-107.
231. Yezierski R.P., Vierck C.J. Reflex and pain behaviors are not equivalent: lessons from spinal cord injury. Pain 2010, 151:569-570.
232. Yezierski R.P., Liu S., Ruenes G.L., Kajander K.J., Brewer K.L. Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain 1998, 75:141-155.
233. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25:181-213.
234. You H.J., Colpaert F.C., Arendt-Nielsen L. Long-lasting descending and transitory short-term spinal controls on deep spinal dorsal horn nociceptive-specific neurons in response to persistent nociception. Brain Res. Bull. 2008, 75:34-41.
235. Young W. Spinal cord contusion models. Prog. Brain Res. 2002, 137:231-255.
236. Zai L.J., Wrathall J.R. Cell proliferation and replacement following contusive spinal cord injury. Glia 2005, 50:247-257.
237. Zhang H., Chang M., Hansen C.N., Basso D.M., Noble-Haeusslein L.J. Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury. Neurotherapeutics 2011, 8:206-220.
238. Zhao P., Waxman S.G., Hains B.C. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 2007, 27:8893-8902.
239. Zhao P., Waxman S.G., Hains B.C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci. 2007, 27:2357-2368.
240. Zhou Y., Wang Y., Abdelhady M., Mourad M.S., Hassouna M.M. Change of vanilloid receptor 1 following neuromodulation in rats with spinal cord injury. J. Surg. Res. 2002, 107:140-144.
241. Zhuang Z.Y., Gerner P., Woolf C.J., Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114:149-159.
242. Zhuang Z.Y., Wen Y.R., Zhang D.R., Borsello T., Bonny C., Strichartz G.R., Decosterd I., Ji R.R. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 2006, 26:3551-3560.